Show simple item record

dc.contributor.authorParker, C
dc.date.accessioned2019-06-24T09:43:54Z
dc.date.issued2018-01
dc.identifier.citationESMO open, 2018, 3 (6), pp. e000451 - ?
dc.identifier.issn2059-7029
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3275
dc.identifier.eissn2059-7029
dc.identifier.doi10.1136/esmoopen-2018-000451
dc.formatElectronic-eCollection
dc.format.extente000451 - ?
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleReport from the ESMO 2018 presidential symposium-Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE.
dc.typeOther
rioxxterms.versionofrecord10.1136/esmoopen-2018-000451
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-01
rioxxterms.typeOther
dc.relation.isPartOfESMO open
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume3
pubs.embargo.termsNot known
dc.contributor.icrauthorParker, Chrisen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0